ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in ESSA Pharma Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −5 vs. Q3 2023
- Shares held
- 34.8M
- +1.30M (+3.9%) vs. Q3 2023
- Total value
- $229.4M
- +$126.0M (+121.9%) vs. Q3 2023
- New holders
- 4
- 10 more added
- Sold out
- 9
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 8,748,629 | $57.7M | 1.45% | 00.0% | Unchanged |
| Bellevue Group AG | 7,898,583 | $52.1M | 0.80% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 4,327,622 | $28.6M | 3.17% | +40,528+0.9% | Added |
| Morgan Stanley | 4,186,578 | $27.6M | 0.00% | +3,895+0.1% | Added |
| PFM Health Sciences, LP | 3,262,500 | $21.5M | 1.29% | −936,753−22.3% | Reduced |
| RTW Investments, LP | 2,298,662 | $15.2M | 0.24% | +2,298,662 | New |
| Adage Capital Partners GP, L.L.C. | 1,135,931 | $7.50M | 0.02% | +93,400+9.0% | Added |
| Janus Henderson Group PLC | 1,089,482 | $7.13M | 0.00% | +1,089,482 | New |
| Rock Springs Capital Management LP | 677,005 | $4.47M | 0.11% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 356,500 | $2.35M | 0.24% | 00.0% | Unchanged |
| Citadel Advisors LLC | 263,607 | $1.74M | 0.00% | +258,132+4,714.7% | Added |
| D. E. Shaw & Co., Inc. | 199,653 | $1.32M | 0.00% | +31,603+18.8% | Added |
| CIBC World Markets Inc. | 111,700 | $737.0K | 0.00% | −37,443−25.1% | Reduced |
| BNP Paribas Arbitrage, SA | 57,466 | $379.3K | 0.00% | +35,771+164.9% | Added |
| Royal Bank of Canada | 30,775 | $203.0K | 0.00% | +29,277+1,954.4% | Added |
| Geode Capital Management, LLC | 26,858 | $177.3K | 0.00% | +7,819+41.1% | Added |
| Renaissance Technologies LLC | 24,234 | $160.0K | 0.00% | +24,234 | New |
| American Century Companies Inc | 20,044 | $132.3K | 0.00% | +20,044 | New |
| Privium Fund Management (UK) Ltd | 20,032 | $132.2K | 0.09% | 00.0% | Unchanged |
| Group One Trading, L.P. | 11,175 | $73.8K | 0.00% | −30,685−73.3% | Reduced |
| BlackRock Inc. | 7,677 | $50.7K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,000 | $39.6K | 0.00% | −6,000−50.0% | Reduced |
| UBS Group AG | 4,895 | $32.3K | 0.00% | +4,730+2,866.7% | Added |
| Simplex Trading, LLC | 4,182 | $27.0K | 0.00% | +513+14.0% | Added |
| Barclays PLC | 971 | $6.41K | 0.00% | −317−24.6% | Reduced |
| TD Waterhouse Canada Inc. | 900 | $5.54K | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $3.96K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 50 | $330 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 48 | $317 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 21 | $139 | 0.00% | −29,406−99.9% | Reduced |
| Bank of America Corp | 8 | $53 | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −842,366−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −473,556−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −95,758−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −84,578−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −56,900−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −15,903−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,188−100.0% | Sold out |
| Hunting Hill Global Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −31−100.0% | Sold out |